Learn more

SERUM INSTITUTE OF INDIA PRIVATE LTD

Overview
  • Total Patents
    90
  • GoodIP Patent Rank
    17,455
  • Filing trend
    ⇩ 7.0%
About

SERUM INSTITUTE OF INDIA PRIVATE LTD has a total of 90 patent applications. It decreased the IP activity by 7.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Republic of Korea and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are EMERGEX VACCINES HOLDINGS LTD, EMERGEX VACCINES HOLDING LTD and SK BIOSCIENCE CO LTD.

Patent filings per year

Chart showing SERUM INSTITUTE OF INDIA PRIVATE LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dhere Rajeev Mhalasakant 54
#2 Pisal Sambhaji Shankar 38
#3 Sabale Rajendra Narayan 21
#4 Zade Jagdish Kamalaji 21
#5 Yeolekar Leena Ravindra 17
#6 Shankar Pisal Sambhaji 17
#7 Mhalasakant Dhere Rajeev 16
#8 Reddy Peddi Reddy Srinivas 13
#9 Chahar Singh Digamber 13
#10 Ghodekar Shashikant Janardan 12

Latest patents

Publication Filing date Title
US2021070890A1 Method for obtaining purified bacterial polysaccharides
JOP20200214A1 Immunogenic compositions against enteric diseases and methods for its preparation thereof
TW202038995A Multivalent vaccine composition
JOP20200037A1 Live attenuated influenza vaccine composition and process for preparation thereof
JOP20190242A1 Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same
PE20210106A1 STABLE VACCINE COMPOSITIONS THAT INCLUDE INTER ALIA A RECOMBINANT LIVE ATTENUATED FLAVIVIRUS AND PROCESS FOR THE PREPARATION OF THE SAME
AU2018262438A1 Method for removal of impurities from bacterial capsular polysaccharide based preparations
TW201932140A Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof
AU2017380842A1 Improved methods for enhancing antibody productivity in mammalian cell culture and minimizing aggregation during downstream, formulation processes and stable antibody formulations obtained thereof
EP3296741A1 Multiplex bead based assay for quantification of multiple types of carrier protein in a multivalent conjugate vaccine composition
US2019175722A1 Multivalent vaccine composition
TW201908481A Improved methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
ZA201604024B Improved feeding strategies and purification processes for monoclonal antibody production
BR112017007089A2 improved methods for enterovirus inactivation, adjuvant adsorption and dose-reduced vaccine compositions obtained therefrom.